mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...

Songwriter and music teacher Steve Young of Stevenage, Hertfordshire, made global news as one of the first people to be given ...

Professor Richard Scolyer tells ABC Radio Sydney that a clinical trial is the next step for his melanoma research, but will ...

Melanoma Companies are involved in targeted therapeutics development with respective active and inactive (dormant or ...

Part of that research is learning which cancers are better candidates for mRNA vaccines to be used as part of the treatment, Kamath said. Things like melanoma, which causes a lot of mutations in ...

The Florida surgeon general in January called for a halt in the use of covid mRNA vaccines. And in Texas, Attorney General ...

Another Phase III study with Canvaxin in melanoma patients (stage IV; n = 496) was also stopped prematurely in 2005. Patients in the vaccine arm of the trial were shown to have worse outcomes than ...

Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with ...

A personalized vaccine demonstrated the potential to induce long-lasting immune response among people with advanced kidney ...

Therapeutic cancer vaccines differ from more traditional ... and late-stage trials include options for melanoma, breast, pancreatic and brain cancers, according to Citeline.

Researchers are also exploring mRNA vaccines for melanoma and cancers of the kidney and lung, which they theorize may respond better because of their ability to mutate more. For Brigham ...